Since CD8+ TloPD-L1hi predicted worse survival in pancreatic cancer, we sought to develop a tumor model that in part mimicked pancreatic cancer with a poorly inflamed phenotype. The gene discussed is CD8A; the disease is pancreatic neoplasm.